• 1. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 2. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 3. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 4. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

Comprehensive Overview of 1-Chloro-5-iodoisoquinoline (CAS No. 1379322-93-6): Properties, Applications, and Industry Insights

1-Chloro-5-iodoisoquinoline (CAS No. 1379322-93-6) is a halogenated isoquinoline derivative that has garnered significant attention in pharmaceutical and materials science research. This compound, characterized by its unique chloro and iodo functional groups, serves as a versatile intermediate in organic synthesis. Its molecular structure enables diverse reactivity, making it valuable for constructing complex heterocyclic frameworks. Researchers frequently explore its potential in drug discovery, particularly for targeting kinase inhibitors and cancer therapeutics, aligning with current trends in precision medicine.

The growing demand for halogenated isoquinolines like 1-Chloro-5-iodoisoquinoline reflects broader industry shifts toward high-value building blocks in medicinal chemistry. Recent studies highlight its role in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal for creating biologically active compounds. This aligns with frequent search queries like "isoquinoline derivatives in drug development" or "halogenated heterocycles applications," underscoring its relevance in modern synthetic workflows.

From a physicochemical perspective, 1-Chloro-5-iodoisoquinoline exhibits stability under standard laboratory conditions, though proper storage in amber vials is recommended due to light sensitivity. Analytical techniques like HPLC and NMR spectroscopy are commonly employed for purity verification, addressing quality concerns frequently raised in academic and industrial forums. The compound’s solubility profile—moderate in polar aprotic solvents—makes it suitable for diverse reaction environments, a topic often discussed in process chemistry optimization threads.

Innovative applications of CAS 1379322-93-6 extend to materials science, where its halogen atoms facilitate supramolecular interactions in organic electronics. This resonates with trending searches on "organic semiconductors" and "small-molecule optoelectronic materials." Furthermore, its use in metal-organic frameworks (MOFs) design has been explored, tapping into the surge of interest in porous materials for gas storage and catalysis.

Regulatory and safety assessments emphasize standard laboratory precautions for handling 1-Chloro-5-iodoisoquinoline, though it remains non-classified under stringent hazard categories. This positions it favorably compared to heavily regulated alternatives, a key consideration for researchers querying "safe halogenated reagents." Suppliers typically provide detailed technical data sheets (TDS) and certificates of analysis (CoA), addressing the procurement-focused questions prevalent in specialty chemical forums.

Future research directions for 1379322-93-6 may explore its enantioselective transformations or incorporation into PROTACs (proteolysis-targeting chimeras), a hot topic in degradation therapeutics. Such advancements would align with the compound’s evolving role in cutting-edge biomedical applications, while maintaining compliance with global chemical regulations and sustainability goals—an aspect increasingly prioritized in researcher inquiries about "green chemistry compatible intermediates."

• 69045-79-0(2-Chloro-5-iodopyridine)
• 1234616-02-4(1-chloro-4-iodo-2,7-naphthyridine)
• 1841079-90-0(1,3-Dichloro-7-iodoisoquinoline)
• 153034-86-7(2-Chloro-4-iodopyridine)
• 1841079-91-1(3-chloro-7-iodo-isoquinoline)
• 1168136-15-9(1,3-dichloro-4-iodoisoquinoline)
• 927801-77-2(1-Chloro-4-iodoisoquinoline)
• 943605-99-0(1-Chloro-5-iodo-6-methylisoquinoline)
• 124467-20-5(2-chloro-6-iodo-quinoline)
• 1965309-12-9(1-Chloro-8-iodo-isoquinoline)